Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Chan

Showing results (571-580 of 582) with videos related to

Pageof 59
Sort By:
Molecular Psychiatry|January 11, 2017
An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestryJ L Meyers, J Zhang, J C Wang, et al.
Science Advances|November 25, 2015
The rice immune receptor XA21 recognizes a tyrosine-sulfated protein from a Gram-negative bacteriumRory N Pruitt, Benjamin Schwessinger, Anna Joe, et al.
Frontiers in Public Health|February 14, 2024
Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infectionKelli N O'Laughlin, Robin E Klabbers, Imtiaz Ebna Mannan, et al.
Nature|August 31, 2022
A microbial supply chain for production of the anti-cancer drug vinblastineJie Zhang, Lea G Hansen, Olga Gudich, et al.
The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.
Nature Medicine|October 2, 2023
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Nature Medicine|January 19, 2024
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
ESMO Open|September 17, 2024
Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomesR Sundar, D K A Chia, J J Zhao, et al.
Nature Microbiology|August 4, 2022
Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countriesM J Carvalho, K Sands, K Thomson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2021
Harmonizing neuropsychological assessment for mild neurocognitive disorders in EuropeMarina Boccardi, Andreas U Monsch, Clarissa Ferrari, et al.
Pageof 59

Showing results (571-580 of 582) with videos related to

Sort By:
Pageof 59
Molecular Psychiatry|January 11, 2017
An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestryJ L Meyers, J Zhang, J C Wang, et al.
Science Advances|November 25, 2015
The rice immune receptor XA21 recognizes a tyrosine-sulfated protein from a Gram-negative bacteriumRory N Pruitt, Benjamin Schwessinger, Anna Joe, et al.
Frontiers in Public Health|February 14, 2024
Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infectionKelli N O'Laughlin, Robin E Klabbers, Imtiaz Ebna Mannan, et al.
Nature|August 31, 2022
A microbial supply chain for production of the anti-cancer drug vinblastineJie Zhang, Lea G Hansen, Olga Gudich, et al.
The Journal of Biological Chemistry|May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionalityD Lee, S A Long, J L Adams, et al.
Nature Medicine|October 2, 2023
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
Nature Medicine|January 19, 2024
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trialMatthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, et al.
ESMO Open|September 17, 2024
Phase I PIANO trial-PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomesR Sundar, D K A Chia, J J Zhao, et al.
Nature Microbiology|August 4, 2022
Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countriesM J Carvalho, K Sands, K Thomson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2021
Harmonizing neuropsychological assessment for mild neurocognitive disorders in EuropeMarina Boccardi, Andreas U Monsch, Clarissa Ferrari, et al.
Pageof 59